define health alcohol wipes
define health, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - purpose antiseptic uses - to decrease bacteria on the skin - recommended for repeated use
define health alcohol wipes (vietnam)
define health, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - purpose antiseptic uses - to decrease bacteria on the skin - recommended for repeated use
cellcept
roche products (nz) ltd - mycophenolate mofetil 250mg; - capsule - 250 mg - active: mycophenolate mofetil 250mg excipient: croscarmellose sodium gelatin magnesium stearate povidone pregelatinised maize starch - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
cellcept
roche products (nz) ltd - mycophenolate mofetil 500mg (as 542 mg of the hydrochloride salt); - powder for infusion - 500 mg - active: mycophenolate mofetil 500mg (as 542 mg of the hydrochloride salt) excipient: citric acid polysorbate 80 sodium chloride - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
cellcept
roche products (nz) ltd - mycophenolate mofetil 200 mg/ml; - powder for oral suspension - 200 mg/ml - active: mycophenolate mofetil 200 mg/ml excipient: aspartame citric acid colloidal silicon dioxide fruit mix flavour 274869 lecithin methyl hydroxybenzoate sodium citrate dihydrate sorbitol xanthan gum - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
cellcept
roche products (nz) ltd - mycophenolate mofetil 500mg; - tablet - 500 mg - active: mycophenolate mofetil 500mg excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry lavender y-5-10272-a povidone - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
cellcept for i.v. infusion 500 mgvial
roche singapore pte. ltd. - mycophenolate mofetil - injection, powder, for solution - 500 mg/vial - mycophenolate mofetil 500 mg/vial
cellcept tablet 500 mg
roche singapore pte. ltd. - mycophenolate mofetil - tablet, film coated - 500 mg - mycophenolate mofetil 500 mg
cellcept capsule 250 mg
roche singapore pte. ltd. - mycophenolate mofetil - capsule - 250 mg - mycophenolate mofetil 250 mg
cellcept 250mg capsules
f. hoffmann-la roche ltd. - mycophenolate mofetil - capsules - 250mg